chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pancreatitis; When she got back home she wasn't feeling well so went back to the hospital two weeks after; She got sick and got into the hospital for 3 weeks; She was supposed to get the second dose on february but the second dose wascancelled due to lack of the product.; second dose was cancelled due to lack of product; This spontaneous case was reported by a consumer and describes the occurrence of PANCREATITIS (Pancreatitis), ILLNESS (She got sick and got into the hospital for 3 weeks) and MALAISE (When she got back home she wasn't feeling well so went back to the hospital two weeks after) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ILLNESS (She got sick and got into the hospital for 3 weeks) (seriousness criterion hospitalization prolonged). On an unknown date, the patient experienced PANCREATITIS (Pancreatitis) (seriousness criteria hospitalization prolonged and medically significant), MALAISE (When she got back home she wasn't feeling well so went back to the hospital two weeks after) (seriousness criterion hospitalization prolonged), PRODUCT AVAILABILITY ISSUE (She was supposed to get the second dose on february but the second dose wascancelled due to lack of the product.) and PRODUCT DOSE OMISSION ISSUE (second dose was cancelled due to lack of product). At the time of the report, PANCREATITIS (Pancreatitis), ILLNESS (She got sick and got into the hospital for 3 weeks) and MALAISE (When she got back home she wasn't feeling well so went back to the hospital two weeks after) outcome was unknown and PRODUCT AVAILABILITY ISSUE (She was supposed to get the second dose on february but the second dose wascancelled due to lack of the product.) and PRODUCT DOSE OMISSION ISSUE (second dose was cancelled due to lack of product) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provide by the reporter.  Treatment information was not provided by the reporter. Very limited information regarding the events "pancreatitis" , "illness" and malaise" has been provided at this time.  Further information has been requested. For the events, product dose omission, product availability issue causality is assessed as not applicable.; Sender's Comments: Very limited information regarding the events "pancreatitis" , "illness" and malaise" has been provided at this time.  Further information has been requested. For the events, product dose omission, product availability issue causality is assessed as not aplicable.
Client received her first dose of Covid 19 vaccine on 1/11/21 at 12:05. Client reported an allergic reaction to Allegra and contrast dye so she was observed for 30 minutes. At around 12:30pm  client began experiencing a rash on upper chest which was reported by client to be slightly itchy . PHN observed rash to be red and raised and blotchy. Client reported her throat was "thick" when swallowing.Client reports no allergies to Benadryl.25mg. of Benadryl administered P.O. by PHN at 12:45pm. Blood pressure at 12:45pm was 158/98 . 911 activated at 12;50pm. At 12:55pm B.P was 190/110 with client complaining of thickness and swelling of throat. 0.5mg of Epinephrine injected IM into left outer thigh. EMS squad arrived at 12:58.Client was taken to facility for evaluation.
Pt was given MENVEO with no reaction, GARDASIL was given 2 minutes later. About one minute later the pt became nauseous and dizzy. Pt was layed down. BP was monitored with normal readings for the pt. An ice pack was placed on the back of the neck. Recovered in 25 min.
patient had immediate onset of metallic taste in her mouth and felt a slight tingling in mouth and slight need to focus on swallowing without any difficulty with breathing;  no sense of doom, no lightheadedness, no palpitations, no problems breathing.   blood pressure was 196/112 with HR of 110 at 4:20 pm, then was 204/112 at 4:28 with pulse of 90;  her heart and lung exams were normal without any  wheezing; speaking in full sentences; she sat and rested for the 30 minutes and her blood pressure returned to 142/97 with pulse of 68.   injection site looked fine and patient was comfortable to go home.
pt received 2nd immunization for covid at 12:15 pm. instead of sitting for 15 minutes as advised, he got up and walked around the store.  At 12:40 pm he returned to the pharmacy claiming to have nausea and feeling like he is about to vomit.  He sat down.  He did not have throat swelling, flushing or paleness, shortness of breath, rash--only nausea. Pt has asthma and verified that he was not wheezing or feeling like it was any type of allergic reaction.  I took his BP:130/79. Pt reported that it usually ranges from 120-130 over 70-80.  pulse was 74 bpm.  Pt reported that he had not eaten anything since breakfast at 6 am.  I gave him some water to drink, and sitting still and drinking water seemed to help him.  I gave him a peppermint to help settle his stomach.  After 20 minutes, he felt well enough to leave.  He was accompanied by his two adult children and instructed to call if any other issues occur.  He reports that he did not have any issues after his first shot at the fairgrounds from county public health.
blister on her cheek; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blister on her cheek), PYREXIA (fever) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). On 10-Mar-2021, the patient experienced BLISTER (blister on her cheek). At the time of the report, BLISTER (blister on her cheek), PYREXIA (fever) and FATIGUE (fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was reported.   No treatment information was reported.
numbness in my arm; chest feels tight; pretty heavily swollen lymph nodes in my armpit left arm pit same side as injected in; they were tender; woke up in pool of sweat; headache; aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 34 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 13Jan2022 (Lot number: FJ5683) at the age of 34 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset Jan2022, outcome "unknown", described as "aches"; HEADACHE (non-serious) with onset 13Jan2022, outcome "unknown", described as "headache"; HYPOAESTHESIA (non-serious) with onset 16Jan2022, outcome "recovering", described as "numbness in my arm"; CHEST DISCOMFORT (non-serious) with onset 16Jan2022, outcome "not recovered", described as "chest feels tight"; HYPERHIDROSIS (non-serious) with onset 13Jan2022, outcome "unknown", described as "woke up in pool of sweat"; LYMPHADENOPATHY (non-serious) with onset 15Jan2022, outcome "recovering", described as "pretty heavily swollen lymph nodes in my armpit left arm pit same side as injected in; they were tender". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, headache, hypoaesthesia, chest discomfort, hyperhidrosis, lymphadenopathy.  Additional Information: He got his booster of the Pfizer covid 19 vaccines, last Thursday and had typical side effects. He had aches, headache, woke up in pool of sweat, the following night on Friday night. On Saturday, woke up with some pretty heavily swollen lymph nodes in armpit left arm pit same side as injected in. They were tender, and then the next day Sunday, he woke up with a little bit of numbness in his arm, same left arm, felt as if when you get your BP taken with blood cuff, it restricts the blood flow, it felt like that. Patient reported arm was a little numb kind of felt like when one gets blood like they put the arm cup on to take your blood pressure, it felt like the blood has been strain of it. This could be related or unrelated, his chest feels tight started, Sunday, Monday, and Tuesday. Lymph nodes not as bad, the numbness he was feel it a little bit, not as noticeable today, but still having the chest tightness. He had read about a lot of the side effects, but he didn't see anything about numbness in arm, some site said it could be an allergic reaction to talk to doctor about. The time of the vaccination was reported as probably noon. No prior vaccination (within 4 weeks). He was not taking other medication.   No follow-up attempts are possible. No further information is expected.
itchiness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itchiness at site of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at site of injection). The patient was treated with PREDNISONE on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency and PEPTIDES NOS on 07-Feb-2021 for Adverse event, at an unspecified dose and frequency. On 05-Feb-2021, INJECTION SITE PRURITUS (itchiness at site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported.
Few hours after vaccine urticaria x 5 days 11/6/15 - 11/10/15.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. Approximately in 2011 (reported as five years ago), the patient first dose in the three dose series of GARDASIL (dosing details, lot# and expiry date were not reported) for prophylaxis. On 09-DEC-2016, the patient came to receive GARDASIL 9 (dosing details, lot# and expiry date were not reported) for prophylaxis. No adverse effects were reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to unspecified number of unspecified patients. On unknown dates the patients were vaccinated with improperly stored RECOMBIVAX HB (lot # K021444 expiration date 17-SEP-2016 and lot # L026598 expiration date 26-JUN-2017). No adverse effects reported. This report is for data logger. The vaccines were exposed to the following exposures: 1.6 degree centigrade for 1 hour 48 minutes (rounds to 2 degree centigrade). 1.4 degree centigrade for 4 hours and 40 minutes. 1.5 degree centigrade for 1 hour 17 minutes (rounds to 2 degree centigrade). Previous excursions included: 1.7 degree centigrade for 25 minutes (rounds to 2 degree centigrade). 1.4 degree centigrade for 2 hours and 32 minutes. 1.4 degree centigrade for 3 hours and 36 minutes. Additional information has been requested.
Nothing serious, just adding for extra data for COVID vaccine studies. I have "COVID arm", swollen, red, warm upper arm/shoulder area, along with continued general fatigue and mild joint pain.
This spontaneous report as received from a nurse refers to unspecified patient of unknown age and gender. No medical history and concurrent conditions were reported. The nurse reported that on an unknown date and time after 02-FEB-2015, unspecified number of patients were vaccinated with GARDASIL 0.5 ml intramuscularly (lot # K007264, expiry date 02-MAR-2017; lot # K007828, expiry date 02-MAR-2017 and lot # K009482, expiry date 06-MAR-2017). On an unspecified date, the vaccine had been improperly stored. No adverse effects were reported. There was no product quality complaints (PQC) involved. The outcome of the event was unknown. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Got achy,; Had a pink lump at injection site; slept a lot; it was itchy right away at injection site; low grade fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Got achy,), INJECTION SITE MASS (Had a pink lump at injection site), HYPERSOMNIA (slept a lot), INJECTION SITE PRURITUS (it was itchy right away at injection site) and PYREXIA (low grade fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure, Thyroid disorder and Cholesterol.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Got achy,), INJECTION SITE MASS (Had a pink lump at injection site), HYPERSOMNIA (slept a lot), INJECTION SITE PRURITUS (it was itchy right away at injection site), PYREXIA (low grade fever) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Got achy,), INJECTION SITE MASS (Had a pink lump at injection site), HYPERSOMNIA (slept a lot), INJECTION SITE PRURITUS (it was itchy right away at injection site), PYREXIA (low grade fever) and FATIGUE (Fatigue) outcome was unknown.            Action taken with vaccine was not applicable. Concomitant medications include blood pressure, thyroid and cholesterol medications.
Had PRP-T and PNCV 7 this AM.  This afternoon was found febrile with yeverdited shaking eyes rolling back.  Presumed febrile seizures.  Etiology of fever vaccine reaction vs viral syndrome.
Approx 7:00 PM I broke out with hives and had major itching all night long and on 10/08/2014 all day, included the majority of my body buttocks, inside thighs, feet, hands, arms. Approximately 8:00 AM my lower lip severely swelled about 3-4X's larger than normal. I put a call into the Dr. office, but they never called back ended up going to the Emergency Room the evening of 10/08/2014. The Dr. diagnosis was "Acute Allergic Reaction" to the flu shot. I was administered famotidine, fexofenadine, and methylprednisolone intravenously and was given prescriptions for Medrol (pak) 4MG #21 tablets, Pepcid 20MG #10 tablets and Allegra 180MG #30 Package.
Patient already received her 3rd (booster) dose on 9/30/21 at the facility she resides in- this was not know at the time of her appointment today or did the patient tell us she just received her boost dose.  A 4th dose was given today, not knowing she just got it a week ago, it did not come up on our immunization history.
102 fever, chills, aches. But most important, swelling of lips a day later. Soreness when touching cheeks. Took antihistamine.
chills; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced chills on an unspecified date. Outcome of event was unknown.  Information on the lot/batch number has been requested.
pt was vaxed 9DEC92 & w/in 24 hrs arm was swollen & red; seen by MD 14DEC92; treated w/Duracef; pt recovered; MD suspects an allergic react & not cellulitis; 21DEC92 pt c/o of knot; following wk knot dissipated;
Post administration of 2nd dose of Pfizer pt.  presented with Dypnea, coughing,and chest tightness. EMS was activated.5L Oxygen administered via nasal cannula . EMS administered albuterol and transferred pt. to hospital.
Client reported itching Wed 9/12/7 evening. Rash and itching increased on 9/13/7 and the evening went to ER
Tinnitus; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3, (booster) single for covid-19 immunisation; covid-19 vaccine janssen (COVID-19 VACCINE JANSSEN) (Batch/Lot number: unknown) as dose 1, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "Tinnitus".  Additional information: Causality: 1) Tinnitus   Action(s) taken with drug: Not applicable  Causality as per reporter (Drug/Vaccine): Possible   Causality as per Mfr. (Drug/Vaccine): Possible  Dechallenge: N/A Rechallenge: N/A Seq.No.: 2 Drug: Tozinameran (TOZINAMERAN), UNKNOWN (TOZINAMERAN) Causality: 1) Tinnitus   Action(s) taken with drug: Not applicable  Dechallenge: N/A Rechallenge: N/A   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A few days after receiving the Shingrix vaccine I started having pain in the area of my right shoulder. At first I thought it was a muscle problem. The pain continued and the site became itchy. I then realized that this was the site where I had shingles about 5 years ago.  It has been very painful and I continue to have problems only in that area. I am taking acetominophen  around the clock  and  a CBD cream for the itch.
The mom noted a rash on arms, legs, face and trunk (1 day post vax). The pt otherwise seemed fine. The pt was seen and diagnosed with urticaria.
lymphadenopathy on neck,Neck lymphadenopathy with measurements of: 9, 8 and 6 mm,Axillary lymphadenopathy with measures 25, 10, 2mm. 2.9,upper left arm lymphadenopathy with measures 2.3,swelling lump in her neck,left external axilla area and 2 other; Felt a lot of pain after receiving the Moderna Covid 19 vaccine; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Felt a lot of pain after receiving the Moderna Covid 19 vaccine) and LYMPHADENOPATHY (lymphadenopathy on neck,Neck lymphadenopathy with measurements of: 9, 8 and 6 mm,Axillary lymphadenopathy with measures 25, 10, 2mm. 2.9,upper left arm lymphadenopathy with measures 2.3,swelling lump in her neck,left external axilla area and 2 other) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A and 059E21A) for COVID-19 vaccination.     Patient had no allergies.  Patient had never tested positive for COVID.  Concomitant products included LOSARTAN and AMLODIPINE BESILATE for an unknown indication.   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Felt a lot of pain after receiving the Moderna Covid 19 vaccine). On 09-Sep-2021, the patient experienced LYMPHADENOPATHY (lymphadenopathy on neck,Neck lymphadenopathy with measurements of: 9, 8 and 6 mm,Axillary lymphadenopathy with measures 25, 10, 2mm. 2.9,upper left arm lymphadenopathy with measures 2.3,swelling lump in her neck,left external axilla area and 2 other). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Felt a lot of pain after receiving the Moderna Covid 19 vaccine) and LYMPHADENOPATHY (lymphadenopathy on neck,Neck lymphadenopathy with measurements of: 9, 8 and 6 mm,Axillary lymphadenopathy with measures 25, 10, 2mm. 2.9,upper left arm lymphadenopathy with measures 2.3,swelling lump in her neck,left external axilla area and 2 other) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Nov-2021, Ultrasound scan: found the lymphadenopathy with measurements of: 9, 8 and 6 mm.. On 28-Jan-2022, Ultrasound scan: found a left axillary lymphadenopathy with the measures 25, 10, 2mm. In July 2022, Ultrasound scan: found an upper left arm lymphadenopathy with measures 2.3, 1.2 and 0,6 centimeters and another one of 2.9, 1.6 and 0.6 centimeters.         The patient informed that doctor said she needs surgery, but she did not understand why, she stated she had not gotten any explanation.
Initial report was received 26 April 2010 from a health care professional. An adult patient (age reported as in their mid 40s), had received an injection of ADACEL (lot number, route, site and date of administration not reported) and an unspecified amount of time later, the patient developed a severe reaction which prompted the physician to call 911. The physician and nurse believed that the patient developed brachial neuritis (transient) which resolved after four to five hours. No additional information was provided at the time of the report. Documents held by sender: None.
The condition is BPH is the condition which has been with me for a while. Unable to urinate, I went to the ER twice. I don't think it is related to the vaccine.
Red, raised bump where injection was administered, the circumference is  about 1/4 inch.   Directly below the injection site there are approximately 8 distinct scattered red raised dots(bumps) surrounded by cloud-like formation of swollen, also raised dark pinkish skin (surrounding  the red bumps), although no distinct borders between the swollen , raised pinkish skin.  The size of this swollen area is about 2 inches in diameter, right below the injection site.   The said area is very warm to touch, but no pain, however it is very itchy. The bumps do not appear to contain fluid.  No break in the skin or bleeding is evident. No nausea, no fainting, no dizziness experienced.  However, slight headache experienced.    Registered nurse on call recommended washing the area with warm water, applying cold compress and placing steroid cream